126 related articles for article (PubMed ID: 33159265)
1. Key factors mediated by PI3K signaling pathway and related genes in endometrial carcinoma.
Liu Z; Hong Z; Ma H; Yu D; Qu P
J Bioenerg Biomembr; 2020 Dec; 52(6):465-473. PubMed ID: 33159265
[TBL] [Abstract][Full Text] [Related]
2. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
Yang L; Cui Y; Sun X; Wang Y
Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
5. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Jiang P; Sun W; Shen N; Huang X; Fu S
BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the characteristics of immune infiltration in endometrial carcinoma and its relationship with prognosis based on bioinformatics.
Lin Y; Liu S; Lin C; Lin P; Teng Z; Zhu G
Medicine (Baltimore); 2023 Jun; 102(25):e34156. PubMed ID: 37352032
[TBL] [Abstract][Full Text] [Related]
7. PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis.
Sohn EJ
BMC Cancer; 2022 Jun; 22(1):708. PubMed ID: 35761259
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Wu H; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of Differently Expressed Genes Reveals a 17-Gene Prognosis Signature for Endometrial Carcinoma.
Wang A; Guo H; Long Z
Biomed Res Int; 2021; 2021():4804694. PubMed ID: 34337010
[TBL] [Abstract][Full Text] [Related]
10. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
Wang Y; Yin L; Sun X
J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer.
Liu A; Zhang D; Yang X; Song Y
J Cell Biochem; 2019 Oct; 120(10):17593-17601. PubMed ID: 31140648
[TBL] [Abstract][Full Text] [Related]
12. Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
Wik E; Trovik J; Kusonmano K; Birkeland E; Raeder MB; Pashtan I; Hoivik EA; Krakstad C; Werner HM; Holst F; Mjøs S; Halle MK; Mannelqvist M; Mauland KK; Oyan AM; Stefansson IM; Petersen K; Simon R; Cherniack AD; Meyerson M; Kalland KH; Akslen LA; Salvesen HB
Gynecol Oncol; 2014 Sep; 134(3):599-606. PubMed ID: 24995579
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics Analysis of Immune Infiltration In Endometrial Carcinoma Tumors and its Relationship With Prognosis.
Lin Y; Liu S; Bian L; Lin C; Lin P; Teng Z; Hoffman RM; Zhu G; Zhang B
Cancer Diagn Progn; 2023; 3(4):416-427. PubMed ID: 37405226
[TBL] [Abstract][Full Text] [Related]
14. HOTTIP regulates progression of endometrial cancer via activating PI3K/AKT pathway.
Guan Q; Zhang Q; Zhang C; Liu Q; Ren QL
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3727-3733. PubMed ID: 29949146
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
[TBL] [Abstract][Full Text] [Related]
17. TMEFF2 is a novel prognosis signature and target for endometrial carcinoma.
Gao L; Nie X; Zheng M; Li X; Guo Q; Liu J; Liu Q; Hao Y; Lin B
Life Sci; 2020 Feb; 243():116910. PubMed ID: 31610211
[TBL] [Abstract][Full Text] [Related]
18. Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.
Wik E; Ræder MB; Krakstad C; Trovik J; Birkeland E; Hoivik EA; Mjos S; Werner HM; Mannelqvist M; Stefansson IM; Oyan AM; Kalland KH; Akslen LA; Salvesen HB
Clin Cancer Res; 2013 Mar; 19(5):1094-105. PubMed ID: 23319822
[TBL] [Abstract][Full Text] [Related]
19. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
Zhang S; Wang M; Li Q; Zhu P
Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
[TBL] [Abstract][Full Text] [Related]
20. Construction of a nine DNA repair-related gene prognostic classifier to predict prognosis in patients with endometrial carcinoma.
Liu J; Jiang P; Chen X; Shen Y; Cui G; Ma Z; Zhao S; Zhang Y
BMC Cancer; 2021 Jan; 21(1):29. PubMed ID: 33407221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
